CoChat

Ureteral endometriosis post-hysterectomy for adenomyosis: a case report and literature review

Open access
Lu, Yujuan, Wang, Yu · 2025 · BMC Urology

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index; 7 of the 29 sources its claims cite were checked for support.

Abstract

OBJECTIVE: To explore the necessity of long-term pharmacological management following total hysterectomy for adenomyosis. METHODS: A case of ureteral endometriosis identified over one year after laparoscopic total hysterectomy and bilateral salpingectomy for adenomyosis was retrospectively analyzed. Clinical data were reviewed, and related literature was summarized for discussion. RESULTS: The patient underwent laparoscopic total hysterectomy and bilateral salpingectomy at our hospital more than one year prior because of adenomyosis. No pharmacological treatment was provided postsurgery. One year later, the patient presented with right lumbar discomfort. Imaging revealed hydronephrosis of the right kidney and dilation of the right ureter, leading to a diagnosis of right ureteral endometriosis. Laparoscopic excision of the ureteral endometriotic lesion was performed. Pathology confirmed right ureteral endometriosis with glandular cystic expansion. Postsurgery, the patient was treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy (3.6 mg of goserelin via subcutaneous injection every 28 days for a total of six cycles). Treatment is ongoing. Follow-up ultrasound revealed no abnormalities in the kidneys or ureters, and no recurrence was observed during the five months of follow-up. CONCLUSION: Adenomyosis is often associated with deep endometriosis. Even if no evident deep pelvic endometriosis is identified during total hysterectomy, long-term pharmacological management postsurgery may still be necessary. This approach can reduce the incidence of deep endometriosis in organs such as the bladder, ureters, and intestines.

Overview

CoChat Summary

TL;DR

This case report describes a 48-year-old woman who developed right ureteral endometriosis more than one year after laparoscopic total hysterectomy and bilateral salpingectomy for adenomyosis, having received no postoperative hormonal therapy. She was treated with laparoscopic excision and six cycles of GnRH-a, with no recurrence at five months, and the authors argue for risk-stratified long-term pharmacological management after hysterectomy for adenomyosis.

Key findings

  • A 48-year-old woman with adenomyosis underwent laparoscopic total hysterectomy and bilateral salpingectomy in March 2023; no endometriotic lesions were seen intraoperatively and no postoperative pharmacological treatment was given.
  • In April 2024, she presented with right lumbar discomfort; CT showed a distal right ureteral soft tissue nodule measuring approximately 24.5 × 16.5 × 18 mm with hydronephrosis and proximal ureteral dilation, and pathology after laparoscopic excision confirmed ureteral endometriosis with glandular cystic expansion.
  • She received postoperative GnRH-a therapy with goserelin 3.6 mg subcutaneously every 28 days for six cycles; follow-up ultrasound five months later showed no kidney, ureter, or bladder abnormalities, and no recurrence was observed.
  • The literature review reports recurrence rates of 28.6% in a conservative surgery group without postoperative hormonal therapy (Di Maida et al., 2022) and 1.2% in 160 patients treated with laparoscopic ureteroneocystostomy plus postoperative hormone therapy (Ceccaroni et al., 2019), supporting postoperative hormonal therapy and complete excision to reduce recurrence.

Methods

  • Retrospective analysis of a single case of ureteral endometriosis identified more than one year after laparoscopic total hysterectomy and bilateral salpingectomy for adenomyosis.
  • Clinical data were reviewed, including laboratory results, pelvic ultrasound, CT, MRI, surgical findings, pathology, treatment, and follow-up.
  • Related literature was summarized in a comparative table of reported ureteral endometriosis case series, including sample size, surgical approach, postoperative hormonal therapy, recurrence rate, and follow-up duration.

Limitations

  • The paper states that causality cannot be established from a single case and that additional clinical studies are warranted to clarify which patient subgroups may benefit from continued pharmacological therapy after definitive surgery.
  • The paper reports follow-up of only five months, so longer-term recurrence risk is not established.
  • Evident from the text: this is a single case report with no control group, and the literature review is a narrative comparative summary rather than a systematic review with defined search or quality-assessment methods.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12894-025-01866-9

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Vaginal ultrasound image of the uterus
Fig. 1 Vaginal ultrasound image of the uterusCC BY-NC-ND · PubMed Central
Fig. 2 CT image of ureteral endometriosis
Fig. 2 CT image of ureteral endometriosisCC BY-NC-ND · PubMed Central
Fig. 3 a Pathological examination (HE staining x200) b Immunohistochemical ER (+) c Immunohistochemical PR (+)
Fig. 3 a Pathological examination (HE staining x200) b Immunohistochemical ER (+) c Immunohistochemical PR (+)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

7 Valid · 0 Not valid · 14 Not checked · 23 Own results and interpretations

17 more claims

Create a free account to see all 44 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 12
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Citations

Cites

Show all 29 references

Research works printed but not linked: 4

  1. Jia Z, Yan-Ni. "Diagnosis and treatment of ureteral endometriosis: an analysis of 28 cases." Master,s thesis, Shanxi Medical University; 2022. CNKI. https://www.cnki.net.
  2. Liu Q, Sun YX, Liu KJ, et al. Analysis of the diagnosis and treatment of ureteral endometriosis by laparoscopic surgery in 16 patients. Chin J Pract Gynecol Obstet. 2019;35(8):934–937.
  3. Zheng H, Qi XR. Interpretation of the ESHRE endometriosis management guidelines. Chin J Fam Plann Gynecol. 2023;15(8):3–7.
  4. Hu LH, Chen Y, Zhou Y, et al. Risk factors for recurrence after laparoscopic conservative surgery in patients with stage III-IV endometriosis. J Int Obstet Gynecol. 2021;48(3):314–317.

Cited by

See all 1

Metadata

Authors
Lu, Y., & Wang, Y.
Affiliations
Chengdu University (CN)
Corresponding author
Lu, Yujuan
Venue
BMC Urology
Published
2025-07-09
Volume
25
Issue
1
Pages
164-164
ISSN
1471-2490 (ISSN-L)
OpenAlex
W4412150527
Cited by
0
References
28
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Urology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
Keywords
ureteral endometriosis, adenomyosis, total hysterectomy, bilateral salpingectomy, deep infiltrating endometriosis, GnRH agonist, goserelin, hydronephrosis, laparoscopic resection, long-term follow-up
MeSH terms
Adult, Endometriosis, Female, Humans, Hysterectomy, Middle Aged, Postoperative Complications, Ureteral Diseases, Adenomyosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ureteral endometriosis post-hysterectomy for adenomyosis: a case report and literature review. https://app.cochat.ai/papers/10.1186/s12894-025-01866-9
The paper
Lu, Y., & Wang, Y. (2025). Ureteral endometriosis post-hysterectomy for adenomyosis: a case report and literature review. BMC Urology. https://doi.org/10.1186/s12894-025-01866-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.